s-nitrosocysteine and 2-2--2---terpyridine

s-nitrosocysteine has been researched along with 2-2--2---terpyridine* in 1 studies

Other Studies

1 other study(ies) available for s-nitrosocysteine and 2-2--2---terpyridine

ArticleYear
Role of redox-active iron ions in the decomposition of S-nitrosocysteine in subcellular fractions of porcine aorta.
    European journal of biochemistry, 2000, Volume: 267, Issue:14

    We recently reported that degradation of S-nitrosocysteine in homogenates of porcine aorta increased severalfold in the presence of Mg2+ ions [Kostka, P., Xu, B. & Skiles, E.H. (1999) J. Cardiovasc. Pharmacol. 33, 665-670]. The objective of the present study was to examine this in greater detail. The rate of S-nitrosocysteine degradation by aortic homogenates in the presence of Mg2+ ions exhibited differential sensitivity to chelators of iron ions. Terpyridine and diethylenetriamine penta-acetic acid (5-500 microM) caused a concentration-dependent inhibition of S-nitrosocysteine decay, whereas deferoxamine (100 microM) was ineffective. o-Phenanthroline (250 microM), a selective chelator of Fe2+ ions, potentiated the reaction at low initial concentrations of S-nitrosocysteine (< or = 15 microM) and inhibited the reaction at higher concentrations. The inhibitory effects of o-phenanthroline were related to suppression of S-nitrosocysteine decay by cysteine-mediated reduction of Fe3+. In the presence of o-phenanthroline, S-nitrosocysteine decomposition followed saturable kinetics with K0.5 = 3.8 +/- 0.3 microM and h = 1.8 +/- 0.1 (mean +/- SE, n = 4). Comparison of the rates of S-nitrosocysteine decay in different subcellular fractions showed selective association with the cytosolic fraction, as documented by copurification with lactate dehydrogenase activity. At non-limiting concentrations of S-nitrosocysteine, the rate of degradation in the cytosolic fraction was 4.1 +/- 0.3 nmol.min-1.(mg protein)-1 (n = 4). It is concluded that the cytosolic fraction of porcine aorta contains a protein factor, presumably an enzyme, capable of catalyzing heterolytic decomposition of the S-NO bond of S-nitrosocysteine in a process involving redox cycling of iron ions.

    Topics: Animals; Aorta; Chelating Agents; Cysteine; Cytosol; Deferoxamine; Dose-Response Relationship, Drug; Ions; Iron; Iron Chelating Agents; Kinetics; L-Lactate Dehydrogenase; Magnesium; Models, Chemical; Muscle, Smooth, Vascular; Nitroso Compounds; Pentetic Acid; Phenanthrolines; Pyridines; S-Nitrosothiols; Swine; Time Factors

2000